TY - JOUR
T1 - Clinical use of intracoronary imaging. Part 1
T2 - Guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions
AU - Document Reviewers
AU - Räber, Lorenz
AU - Mintz, Gary S.
AU - Koskinas, Konstantinos C.
AU - Johnson, Thomas W.
AU - Holm, Niels R.
AU - Onuma, Yoshinubo
AU - Radu, Maria D.
AU - Joner, Michael
AU - Yu, Bo
AU - Jia, Haibo
AU - Meneveau, Nicolas
AU - De La Torre Hernandez, Jose M.
AU - Escaned, Javier
AU - Hill, Jonathan
AU - Prati, Francesco
AU - Colombo, Antonio
AU - Di Mario, Carlo
AU - Regar, Evelyn
AU - Capodanno, Davide
AU - Wijns, William
AU - Byrne, Robert A.
AU - Guagliumi, Giulio
AU - Alfonso, Fernando
AU - Bhindi, Ravinay
AU - Ali, Ziad
AU - Carter, Rickey
N1 - Funding Information:
Conflict of interest: Dr. F. Alfonso has nothing to disclose. Dr. Z. Ali reports grants from Cardiovascular System Inc, Abbott Vascular, personal fees from Cordis, Canon USA, Abbott Vascular, Boston Scientific, Acist Medical, Opsens. Dr. R. Bhindi reports grants from National Heart Foundation of Australia, personal fees from Bristol Myers Squibb, Astra Zeneca, Medtronic. Dr. R. Byrne reports grants from HeartFlow, Boston Scientific, personal fees from Boston Scientific, Biotronik, B.Braun. Dr. D. Capodanno reports personal fees from Bayer, Daiichi Sankyo, Pfizer, Astra Zeneca, Abbott, Direct Flow Medical. Dr. R. Carter has nothing to disclose. Dr. A. Colombo has nothing to disclose. Dr. J.M. de La Torre Hernandez reports grants from Boston Scientific, Medtronic, Biotronik, Abbott Vascular. Dr. C. Di Mario reports grants from Volcano, Abbott, Medtronic, Shockwave. Dr. J. Escaned reports personal fees from Astra Zeneca, Philips Volcano, Abbott, Medtronic, Orbus Neich, Boston Scientific. Dr. G. Guagliumi reports grants from Boston Scientific, Abbott, personal fees from Abbott, Boston Scientific. Dr. J. Hill reports grants from Boston Scientific, Abbott Vascular, personal fees from Boston Scientific, Abbott Vascular, Abiomed. Dr. N.R. Holm reports grants from Abbott, Terumo Inc, REVA Medical, Medis medical imaging, Abbott, Boston Scientific, personal fees from REVA Medical, Abbott, Terumo Inc. Dr. H. Jia has nothing to disclose. Dr. T. Johnson reports personal fees from Boston Scientific, Terumo Inc, Abbott Vascular, Daiichi Sankyo, Astra Zeneca. Dr. M. Joner reports grants from European Society of Cardiology, personal fees from Orbus Neich, Biotronik, Astra Zeneca. Dr. K. Koskinas reports personal fees from Amgen, Sanofi Aventis. Dr. N. Meneveau reports grants from Abbott Vascular, Daiichi Sankyo, personal fees from BMS/Pfizer, Abbott Vascular, Boehringer-Ingelheim, Daiichi Sankyo, Bayer Healthcare, Edwards Life Sciences. Dr. G. Mintz reports grants from Boston Scientific, Volcano, Abbott Vascular, personal fees from Boston Scientific, Volcano, Infraredx, Abbott Vascular. Dr. Y. Onuma reports personal fees from Abbott Vascular. Dr. F. Prati reports personal fees from Abbott. Dr. L. Rðber reports grants from Abbott, Sanofi Aventis, personal fees from Abbott, Amgen, Astra Zeneca, Biotronik, CSL Behring, Sanofi Aventis. Dr. M. Radu reports personal fees from Abbott. Dr. E. Regar reports grants from Abbott, personal fees from Abbott. Dr. W. Wijns reports grants from Abbott Vascular, MICELL, Microport, personal fees from Microport. Dr. B. Yu has nothing to disclose.
Publisher Copyright:
© Published on behalf of the European Society of Cardiology. All rights reserved. The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.
PY - 2018/9/14
Y1 - 2018/9/14
N2 - This Consensus Document is the first of two reports summarizing the views of an expert panel organized by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) on the clinical use of intracoronary imaging including intravascular ultrasound (IVUS) and optical coherence tomography (OCT). The first document appraises the role of intracoronary imaging to guide percutaneous coronary interventions (PCIs) in clinical practice. Current evidence regarding the impact of intracoronary imaging guidance on cardiovascular outcomes is summarized, and patients or lesions most likely to derive clinical benefit from an imaging-guided intervention are identified. The relevance of the use of IVUS or OCT prior to PCI for optimizing stent sizing (stent length and diameter) and planning the procedural strategy is discussed. Regarding post-implantation imaging, the consensus group recommends key parameters that characterize an optimal PCI result and provides cut-offs to guide corrective measures and optimize the stenting result. Moreover, routine performance of intracoronary imaging in patients with stent failure (restenosis or stent thrombosis) is recommended. Finally, strengths and limitations of IVUS and OCT for guiding PCI and assessing stent failures and areas that warrant further research are critically discussed.
AB - This Consensus Document is the first of two reports summarizing the views of an expert panel organized by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) on the clinical use of intracoronary imaging including intravascular ultrasound (IVUS) and optical coherence tomography (OCT). The first document appraises the role of intracoronary imaging to guide percutaneous coronary interventions (PCIs) in clinical practice. Current evidence regarding the impact of intracoronary imaging guidance on cardiovascular outcomes is summarized, and patients or lesions most likely to derive clinical benefit from an imaging-guided intervention are identified. The relevance of the use of IVUS or OCT prior to PCI for optimizing stent sizing (stent length and diameter) and planning the procedural strategy is discussed. Regarding post-implantation imaging, the consensus group recommends key parameters that characterize an optimal PCI result and provides cut-offs to guide corrective measures and optimize the stenting result. Moreover, routine performance of intracoronary imaging in patients with stent failure (restenosis or stent thrombosis) is recommended. Finally, strengths and limitations of IVUS and OCT for guiding PCI and assessing stent failures and areas that warrant further research are critically discussed.
KW - Coronary artery disease
KW - Intracoronary imaging
KW - Intravascular ultrasound
KW - Optical coherence tomography
KW - Percutaneous coronary intervention (PCI)
UR - http://www.scopus.com/inward/record.url?scp=85051085761&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85051085761&partnerID=8YFLogxK
U2 - 10.1093/eurheartj/ehy285
DO - 10.1093/eurheartj/ehy285
M3 - Article
C2 - 29790954
AN - SCOPUS:85051085761
SN - 0195-668X
VL - 39
SP - 3281
EP - 3300
JO - European heart journal
JF - European heart journal
IS - 35
ER -